Chugai Pharmaceutical Co., Ltd.

Chugai Pharmaceutical Co., Ltd. (Japan) holds 0 active US FDA Type II Drug Master Files and 5 inactive, has DMF or CEP filings on record for 1 active ingredient and is linked to 3 FDA-registered manufacturing sites. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Chugai Pharmaceutical Co., Ltd.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/chugai-pharmaceutical-co-ltd

Overview

Chugai Pharmaceutical Co., Ltd. is a leading Japanese pharmaceutical company focused on the research and development of innovative medicines. It operates as a subsidiary of the Roche Group, utilizing its global resources while maintaining its operational independence to develop novel therapies mainly in the oncology and inflammation fields.

Core services & business areas

Drug DevelopmentRegulatory AffairsCommercialization

Therapeutic areas

Active ingredients with DMF or CEP filings

Substances for which Chugai Pharmaceutical Co., Ltd. holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Chugai Pharmaceutical Co., Ltd. holds 0 active (5 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • OCT (MAXACALCITOL)Inactive1998-03-26
  • CCA (LOBENZARIT SODIUM) BULK DRUGInactive1987-11-02
  • CCA (LOBENZARIT SODIUM) TABLETSInactive1987-11-02
  • SG-75 (NICORANDIL) BULK DRUG PRODUCTInactive1986-12-11
  • SG-75 (N-(2-HYDROXYETHYL) NICOTINAMIDE NITRATE TABSInactive1981-04-01

Registered manufacturing sites (3)

Physical sites registered with the US FDA and resolved to Chugai Pharmaceutical Co., Ltd., with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Chugai Pharmaceutical Co., Ltd. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Chugai Pharmaceutical Co., Ltd.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.